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Original article
Correlation between glomerular filtration rate and 
urinary N acetyl-beta-D glucosaminidase in children 
with persistent proteinuria in chronic glomerular 
disease
Purpose: Urinary excretion of N acetyl-beta-D glucosaminidase (NAG) 
and β2-microglobulin (β2-M) was increased in the presence of proximal 
tubular damage. Based on these urinary materials, we investigated the 
ability of expecting renal function in chronic glomerular diseases. In 
this study, we evaluated the relationship between glomerular filtration 
rate (GFR) urinary NAG, and urinary β2-M.  
Methods: We evaluated 52 children with chronic kidney disease at 
the Chung-Ang University Hospital between January 2003 and August 
2009. We investigated the 24-hour urinalysis and hematologic values 
in all 52 patients. Serum creatinine, creatinine clearance (Ccr), serum 
cystatin C, urinary β2-M and urinary NAG were measured. 
Results: Out of 52 patients, there were 13 children with minimal 
change in disease, 3 children with focal segmental glomerulosclerosis, 
17 children with immunoglobulin A nephropathy, 15 children with 
Henoch-Schönlein purpua nephritis, 3 children with poststreptococcal 
glomerulonephritis, and 1 child with thin glomerular basement 
membrane disease. In these patients, there were significant correlation 
between the Ccr and urinary NAG (r=-0.817; P<0.01), and between 
the GFR (as determined by Schwartz method) and urinary NAG (r=-
0.821; P<0.01). In addition, there was a significant correlation between 
the GFR (as determined by Bokencamp method) and urinary NAG (r=-
0.858; P<0.01). 
Conclusion: In our study, there was a significant correlation between 
the GFR and urinary NAG, but there was no correlation between the 
GFR and urinary β2-M, suggesting that the GFR can be predicted by 
urinary NAG in patients with chronic glomerular disease. 
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Intruduction
Proteinuria is defined as a condition where urinary protein level 
is greater than 150 mg/24-hour in adults, and greater than 4 mg/
m
2/hr in children. Chronic glomerular nephritis occurs when 
proteinuria continues for more than a 3 month period
1). Proteinuria 
exists as several forms; there is glomerular proteinuria that is caused 
by loss of the function of the glomerular barrier, and tubular 
proteinuria that is caused by failure of resorption of protein that 
filtrates in the gluomerulus
2). The kidney diseases that chief symptom 
is proteinuria have different patholgical findings; in nephrotic 
syndrome, glomerular injury appears in the early period of nephrotic 
syndrome, and progressive tubular injury appears in late period, and 
in tubulointerstitial disease, tubular dysfunction appears in the early 
period, and secondary glomerular injury appears in the late period
3). 
The urinary excretion of β2-microglobulin (β2-M) and N- acetyl-β-
D-glucosaminidase (NAG) has been used as a marker of renal tubular 
cell injury. β2-M is a small circulating protein with a molecular weight 
of 11,800, which is partly filtrated at the glomerulus. After glomerular 
filtration, β2-M is normally 99.9% reabsorbed in proximal tubule 
and degradated in the lysosome of the renal tubular cell, and finally 
it is excreted in the urine
4,5). In tubular disorders, this mechanism is 
impaired, and urinary excretion of β2-M is increased. NAG is one 
of the low molecular weight proteins found in high concentrations 
in the lysosomes of renal proximal tubules. The increase of urinary 
excretion of NAG usually implies there is renal tubular injury
6).  
Glomerular filtration rate (GFR) is widely used as the best 
mea  surement of kidney function. Serum creatinine is most 
commonly used to estimate GFR because it can be filtrated through 
glomerular basement membrane freely, and is not reabsorbed in the 
proximal tubule
7,8). The creatinine clearance is measured by serum 
creatinine using the Schwartz method (K [coefficient]×[height/
serum creatinine])
9). It may also be measured by the Bokencamp 
method (137/cystatin C-20.4)
10). The decrease of GFR indicates the 
glomerular injury, and the increase of excretion of tubular enzyme 
indicates the tubular injury. As the kidney disease is chronic and the 
proteinuria continues, the glomerular injury can have an effect on 
the tubular injury; the increase of the protein that is filtrated through 
the glomerulus can have an effect on reabsorption of the protein 
in the renal tubule. We hypothesize that evaluation of the urinary 
tubular enzyme can be helpful to predict kidney function in chronic 
glomerular disease.
In this study, we evaluated the association of the GFR and urinary 
β2-M and urinary NAG in children with chronic kidney disease, and 
we evaluated glomerular function estimated by urinary β2-M and 
urinary NAG measurement in chronic kidney disease.
Materials and methods
1. Study population
Fifty-two children with various chronic glomerular disease, who 
had continuous proteinuria (≥4 mg/m
2/hr) for more than 3 months, 
were examined at the Department of Pediatric Nephrology at 
Chung-Ang University Hospital, Seoul between Janunary 2003 and 
August 2009. From the group 28 patients were male and 24 female, 
the mean age was 8.1 years, and the mean body weight was 30.6 kg.  
Of these 52 patients, 13 children were diagnosed with minimal 
change disease, 3 children diagnosed with focal segmental glo-
merulosclerosis, 17 children with immunoglobulin A nephropathy, 
15 children with Henoch-Schönlein purpura nephritis, 3 children 
with poststreptococcal glomerulonephritis, and 1 child was diagnosed 
with thin glomerular basement membrane disease (Table 1). 
Nineteen patients were categorized with stage 1 chronic kidney 
disease, 27 patients were stage 2, 5 patients were stage 3, and 1 patient 
was stage 4 (Table 2). 
2. Materials
We obtained urinary samples in the early morning and investigated 
the 24-hour urinalysis and the hematologic values in all of 52 patients. 
Serum creatinine, creatinine clearance, serum cystatin C, urinary 
β2-M and urinary NAG were measured in these patients. 
The venous blood samples were kept in a freezer at -20˚C. Twenty-
four hours urinary samples were kept in a freezer at -20˚C, and we 
added 1.0 NaOH to the urine samples to prevent β2-M degradation 
Table 1. Distribution of Glomerular Disease Found in a Study Population
Renal diseases      No. (%)
Minimal change disease 13 (25.0)
Focal segmental glomerulosclerosis 3 (5.8)
Henoch-Schönlein purpura nephritis 15 (28.8)
Immunoglobulin A nephropathy 17 (32.7)
Poststreptococcal glomerulonephritis 3 (5.8)
Thin glomerular basement membrain disease 1 (1.9)
Total 52 (100)
Table 2. Distribution of Stages of Chronic Kidney Disease in a Study 
Population
Stage GFR (mL/min/1.73 m
2)  No. (%)
 1 >90 19 (36.6)
 2 60-89 27 (51.9)
 3 30-59 5 (9.6)
 4 15-29 1 (1.9)
 5 <15 0 (0)
Total 52 (100)
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in the acidic urine. We measured β2-M by radioimmunoassay using 
Coat A-Conunt Beta-2 Microglobulin IRMA kit (Diagnostic 
Products Co., Los Angeles, CA, USA). Serum cystatin C was 
measured by the particle enhanced nephelometric immunoassay 
(Dade Behring Marburg GmbH, Marburg, Germany). 
We investigated the association of the GFR and the urinary β2-M and 
the urinary NAG in patients with proteinuria. GFR was estimated by 
measuring creatinie clearance using both Schwartz and Bokencamp 
methods. We also evaluated the association of the creatinine clearance 
and the urinary β2-M and the urinary NAG at the each stage of 
chronic kidney disease.     
3. Statistical analysis
We used the SPSS ver. 15.0 (SPSS Inc., Chicago, IL, USA) for 
statistical analysis. Data were expressed as mean values and the 
variables were evaluated by Pearson’s correlation. Differences were 
considered significant with P value<0.05. 
Results
1. Correlation between GFR and urinary NAG in children 
with chronic glomerular disease
We evaluated the correlation between the GFR and the urinary 
NAG by measuring creatinine clearance using both Schwartz and 
Bokencamp methods. There was a negative correlation between the 
creatinine clearance and the 24-hour urinary NAG in all patients 
with chronic proteinuria (r=-0.817; P<0.01) (Fig. 1). AS well there was 
a negative correlation between the 24-hour urinary NAG and the 
GFR by Schwartz method (r=-0.821; P<0.01) (Fig. 2). We found a 
negative correlation between the 24-hour urinary NAG and the GFR 
by Bokencamp method (r=-0.858; P<0.01) (Fig. 3).
2. Correlation between GFR and urinary β2-M in children 
with chronic glomerular disease 
The correlation between GFR and urinary β2-M using creatinine 
clearance was evaluated using both Schwartz and Bokencamp 
methods. There was no correlation between the creatinine clearance 
and the 24-hour urinary β2-M among the patients with chronic 
proteinuria (r=-0.132; P=0.352) (Fig. 4). There was also no correlation 
between the 24-hour urinary β2-M and the GFR by Schwartz 
method (r=-0.123; P=0.386) (Fig. 5). Additionally, there was no 
correlation between the 24-hour urinary β2-M and the GFR by 
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Fig. 1. Correlation between creatinine clearance and 24-hour urinary 
N-acetyl-β-D-glucosaminidase (NAG) in children with chronic kidney 
disease (r=-0.817; P<0.01). 
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Fig. 2. Correlation between glomerular filtration rate (GFR), as mea-
sured by Schwartz method and 24-hour urinary N-acetyl-β-D-glu-
cosaminidase (NAG) in children with chronic kidney disease (r=-0.821; 
P<0.01).
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Fig. 3. Correlation between glomerular filtration rate (GFR), as mea-
sured by Bokencamp method and 24-hour urinary N-acetyl-β-D-glu-
cosaminidase (NAG) in children with chronic kidney disease (r=-0.858; 
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correlation between the creatinine clearance and the 24-hour urinary 
NAG (r=-0.888; P=0.044) (Fig. 7). But, in stage 1 chronic kidney 
disease, there was no correlation between the creatinine clearance 
and the 24-hour urinary β2-M (r=-0.017; P=0.945). In stage 2 chronic 
kidney disease, there was no correlation between the creatinine 
clearance and the 24-hour urinary β2-M (r=-0.020; P=0.922), as was 
also the case in stage 3 chronic kidney disease, where there was no 
correlation between the creatinine clearance and the 24-hour urinary 
β2-M (r=-0.632; P=0.253) (Fig. 8).
Discussion
In this study, there was a negative correlation between the 
creatinine clearance and the 24-hour urinary NAG and no correlation 
between the creatinine clearance and the 24-hour urinary β2-M in all 
patients with chronic proteinuria. These results are consistent when 
they are compared using both Schwartz and Bokencamp methods 
for evaluation. In each stage of chronic kidney disease, there was a 
negative correlation between the creatinine clearance and the 24-hour 
urinary NAG and no correlation between the creatinine clearance 
and the 24-hour urinary β2-M. 
Among the several methods for evaluating the kidney func-
tion, the calculation of GFR is one of the most common 
methods. GFR is the measure of clearance of inulin, iohexol, Cr-
ethylenediaminetetraacetic acid, TC-diethylene triamine penta-
acetic acid and I-iothalamate, which are extracorporeal materials, and 
is also the measure of the clearance of serum creatinine, blood urea 
nitrogen and β2- microglobulin, which are body materials. In the 
clinical field, serum creatinine is the most commonly used because of 
Bokencamp method (r=-0.231; P=0.099) (Fig. 6).
3. Correlation between the creatinine clearance with 
respect to urinary NAG and urinary β2-M in the children 
with chronic glomerular disease 
We evaluated the correlation between the GFR and the urinary 
NAG as well as with urinary β2-M using creatinine clearance in each 
stage of chronic kidney disease. In stage 1 chronic kidney disease, 
there was a negative correlation between the creatinine clearance and 
the 24-hour urinary NAG (r=-0.503; P=0.028). In stage 2 chronic 
kidney disease, there was a negative correlation between the creatinine 
clearance and the 24-hour urinary NAG (r=-0.651; P<0.01). With 
regards to stage 3 chronic kidney disease, there was again a negative 
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Fig. 4. Correlation between creatinine clearance and 24-hour urinary 
β2-microglobulin (β2-M) in the children with chronic kidney disease (r=-
0.132; P=0.352).
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Fig. 5. Correlation between glomerular filtration rate (GFR), as measured 
by Schwartz method and 24-hour urinary β2-microglobulin (β2-M) in 
children with chronic kidney disease (r=-0.123; P=0.386).
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Fig. 7. Correlation between creatinine clearance and 24-hour urinary 
N-acetyl-β-D-glucosaminidase (NAG) in children with chronic kidney 
disease. (A) Stage 1 (r=-0.503; P=0.028), (B) stage 2 (r=-0.651; P< 0.01) 
and (C) stage 3 chronic kidney disease (r=-0.888; P=0.044) are shown.
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β2-microglobulin (β2-M) in children with chronic kidney disease. (A) 
Stage 1 (r=-0.017; P=0.945), (B) stage 2 (r=-0.020; P=0.922) and (C) 
stage 3 chronic kidney disease (r=-0.632; P=0.253) are shown.
several advantages: it can filtrate through the glomerulus freely and 
is not reabsorbed in the proximal tubule, and additionally it has cost 
effectiveness
7,8). In this study, the creatinine clearance is represented by 
serum creatinine measurement, and evaluated by Schwartz method 
(K [coefficient] × [height/serum creatinine])
9). It can also be measured 
by the Bokencamp method (137/cystatin C-20.4)
10). Cystatin C is 
a non-glycosylated protein which consists of 122 amino acids. It is 
synthesized in nucleated cells, and can filtrate through the glomerular Korean J Pediatr 2012;55(4):136-142 • http://dx.doi.org/10.3345/kjp.2012.55.4.136    141
basement membrane freely and is reabsorbed in the proximal tubule. 
Thus, the serum concentration of cystatin C is dependent on the 
GFR
11,12). 
There are many studies for proteins and enzymes as markers for 
early detection of renal tubular injury; β2-M, retinol-binding protein, 
alpha1-microglobulin, NAG
13). 
Bazzi et al.
14) had studied urinary NAG as a marker of tubular 
injury. They measured the urinary NAG of patients with primary 
glomerulonephritis, and concluded that urinary NAG excretion 
could be considered as a marker of tubular damage in the early stage 
of glomerulonephritis, and might be an effective non-invasive test for 
assessing the damage. NAG is a low molecular weight protein and 
is found in high concentrations in the lysosomes of renal proximal 
tubules. The increase of urinary excretion of NAG means that there 
is renal tubular injury. NAG, especially the isoenzyme A, is in the 
lysosome of the renal tubular cell, and most urinary NAG comes 
from the renal tubular cell
6). The urinary NAG has been used as a 
marker of renal tubular cell injury, and it increases in glomerular 
nephritis, diabetes mellitus nephritis, cadmium poisoning, radio-
graphic agent nephropathy, chronic pyelonephritis
15-17). 
In our study, we measured the level of urinary NAG in patients 
with glomerulonephritis, and evaluated the correlation between the 
urinary NAG and GFR. We found that as the glomerular nephritis 
was progressive, where GFR is typically lower, the excretion of urinary 
NAG increased. Our results are similar to Bazzi’s study.  
According to Piscator
13), the urinary β2-M is a good marker for 
early detection of proximal tubular damage. β2-M is isolated from 
the urine of patient with Wilson’s disease and chronic cadmium 
poisoning by Berggard and Bearn
18) in 1986. β2-M is naturally 
made in most nucleated cells, especially lymphocytes, and it exists 
in serum, urine, cerebrospinal fluid, saliva, and ascites
19,20). β2-M is a 
small circulating protein with a molecular weight of 11,800, which is 
partly filtrated at the glomerulus. After glomerular filtration, β2-M is 
normally 99.9% reabsorbed in the proximal tubule and degradated 
in the lysosome of the renal tubular cell, and finally excreted in the 
urine
4,5). The excretion of urinary β2-M dose not always increase 
when the serum β2-M increases, and it can increase when the 
reabsorption decreases due to dysfunction of renal proximal tubule; 
cadmium poisoning, mercury poisoning, Balkan nephropathy, 
tubule injury due to antibiotics, acute glomerular nephritis, renal 
failure, urogenital malformation
21,22). In rheumatic arthritis, systemic 
lupus erythematosis, Crohn’s disease, chronic liver disease, leukemia, 
and lymphoma, the concentration of serum β2-M increases. If these 
disorders do not exist, the concentration of serum β2-M is dependent 
on the GFR, and the excretion of urinary β2-M is dependent on the 
function of the proximal renal tubule
23,24). 
In our study, we measured the level of the urinary β2-M in patients 
with glomerulonephritis, and evaluated the correlation between the 
urinary β2-M and the GFR. We found that there was no correlation 
between urinary β2-M and GFR, which was a different result in 
relation to urinary NAG although both urinary NAG and urinary 
β2-M are considered markers of tubular injury. 
In Sherman’s study, both urinary NAG and urinary β2-M 
increased in patients with progressive glomerulonephritis. Sherman et 
al.
17) had shown that there was a tubulointerstitial involvement in the 
renal parenchymal diseases. Our results of study about urinary β2-M 
is different from that of Sherman’s study.
Chiaramonte had conducted studies regarding urinary NAG 
and urinary β2-M in patients with renal disease. He found that both 
urinary NAG and urinary β2-M increased further in the progressive 
renal disease, and he concluded that these were useful and accurate 
markers of renal injury progression
23). In our study, we evaluated 
urinary NAG and urinary β2-M in each of the three stages of renal 
disease, which was classified by GFR. Chronic kidney disease is 
classified into five stages by GFR. Stage 1 is characterized by slightly 
diminished function with normal or relatively high GFR (>90 mL/
min/1.73 m
2). In stage 2 there is mild reduction in GFR (60 to 89 
mL/min/1.73 m
2), stage 3 consists of moderate reduction in GFR 
(30 to 59 mL/min/1.73 m
2), stage 4 has a severe reduction in GFR 
(5 to 29 mL/min/1.73 m
2), and stage 5 is established kidney failure 
(<15 mL/min/1.73 m
2)
1). In our study, we found that as the stage was 
higher, the correlation between urinary NAG and GFR was a more 
steep negative coefficient of correlation.
Based on our findings, we believe that the urinary NAG can be 
used to predict the function of the glomerulus in chronic kidney 
disease. We also suggest further investigation is necessary in larger 
patient populations, along with follow-up studies. As well, further 
studies to investigate the differences between urinary NAG and 
urinary β2-M as evaluation markers will be necessary.  
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